CSI Market
Sign In | Register

Trinity Biotech Plc (TRIB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TRIB Annual Cash Flow →
Examining cash flow movements between Trinity Biotech Plc and Dec 31 2024 reveals how Dec 31 2025 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income0.00
Depreciation & amortization1.30
Amortization of Other Assets1.39
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss PropertyPlant And0.03
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Adjustments For Unrealised Foreign Exchange Losses Gains-1.10
Loan Forgiveness-
Inventory Allowance-
Increase Decrease In Estimated Warranty Liability-
Increase Decrease In Contract With Customer Liability-
Increase Decrease In Current Deposits-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities-6.14
Increase (Decrease) in Receivables0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.00
Increase (Decrease) in Interest Payable, Net0.00
Deferred Revenue and Customer Advances and Deposits0.00
Other Adjustments To Reconcile Profit Loss-0.19
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-25.00
Discontinued operations0.00
Net Cash flow from Operating Activities-11.51
Investing Activities
Capital Expenditures-0.09
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Proceeds From Disposal Of Noncurrent Assets Or Disposal Groups Classified As Held For Sale And0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-6.14
Discontinued operations0.00
Net Cash Flow from Investing Activities-6.22
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments15.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-2.55
Operating Lease Payments-
Payments On Operating Lease Liability Financing Activity-
Direct Incremental Costs-
Shareholder Contribution-
Proceeds From Loan Payable-
Forgiveness Of Cares Act Loan-
Finance Lease Principal Payments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities12.05
Effect of exchange rate on cash flow0.07
Discontinued operations0.00
Free Cash Flow-11.60
Total Cash Flow-5.61
4 historic quarters locked

Sign in to unlock the full Trinity Biotech Plc cash flow history.

Sign In Create Free Account

About Trinity Biotech Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001554855-26-000848

Figures are derived from filed reports and may be restated. Historical data is subject to revision.